Metadichol Enhances CD14 Expression in Stem Cells

Metadichol induces CD14 glycoprotein expression in human embryonic stem cells and fibroblasts

P.R. Raghavan

Nanosrc Inc., PO Box 131, Chappaqua, NY 10514, USA

[email protected]

OPEN ACCESS

Published 31 May 2025

CITATION

Raghavan P.R. 2025. Metadichol induces CD14 glycoprotein expression in human embryonic stem cells and fibroblasts. Medical Research Archives, [online] 13(5). https://doi.org/10.18103/mra.v13i5.4849

Abstract

Cluster of differentiation 14 (CD14) is a glycoprotein central to the immune system that is found primarily on monocytes, macrophages, and other immune cells. Despite its importance, there are no examples in the literature highlighting the ability of metadichol to enhance CD14 expression in human embryonic stem cells (hESCs) remaining underexplored, presenting a unique opportunity for novel therapeutic interventions.

Keywords

CD14, metadichol, human embryonic stem cells, fibroblasts, immune response

Introduction

Cluster differentiation 14 (CD14) is a glycoprotein essential to the immune response that recognizes lipopolysaccharides (LPSs) from bacterial cell walls. This interaction significantly enhances the immune response to bacterial infections, making CD14 a key component in pathogen recognition and immune activation. However, the expression and functional implications of CD14 in human embryonic stem cells (hESCs) remain underexplored, presenting a unique opportunity for novel therapeutic interventions.

Experimental

All work was performed in accordance with the guidelines of the Indian Science Trust, Ltd. (Bangalore, India), and the antibodies used were from Elabscience (Houston, Texas, USA). hESC BGO1V and NHDF cells were obtained from ATCC.

Cell culture

Human embryonic stem cells (hESCs) were maintained in suitable media with 20% fetal bovine serum and 1% antibiotics in a humidified atmosphere at 37°C. The cells were passaged every 3-4 days, and the expression of CD14 was monitored using qRT-PCR and Western blotting.

Quantitative real-time PCR

RNA was extracted using TRIzol (Invitrogen, CA, USA) and cDNA synthesis was carried out using a reverse transcriptase kit (TAKARA, Shiga, Japan) with oligo dT primers according to the manufacturer’s instructions. The reaction volume was set to 20 µL, and cDNA synthesis was performed at 50°C for 30 minutes, followed by RT inactivation at 85°C for 5 minutes in a thermal cycler (Applied Biosystems, Foster City, CA, USA). The cDNA was further used for real-time PCR analysis.

Figure 1: RT-PCR showing CD14 upregulation in hESCs
Figure 1: RT-PCR showing CD14 upregulation in hESCs

Western blotting

Protein was extracted from hESCs and analyzed using SDS-PAGE followed by Western blotting. The membranes were probed with specific antibodies against CD14 and GAPDH.

Figure 2: Western blot of CD14 protein expression in hESCs
Figure 2: Western blot of CD14 protein expression in hESCs

Results

The expression of CD14 in hESCs was significantly enhanced by metadichol treatment. The results indicated that metadichol exerts an influence on CD14 expression in hESCs.

Figure 3: qRT-PCR showing CD14 expression in NHDF
Figure 3: qRT-PCR showing CD14 expression in NHDF

Discussion

The downregulation of CD14 in fibroblasts by metadichol could imply a reduction in the inflammatory response typically mediated by these cells. Fibroblasts are involved in wound healing and tissue repair, and their role in inflammation is crucial.

Table 1

Primer Sequence Size Temperature
GAPDH GTCCTCCTGACTTCAACAGG 186 50
CD-14 ACGACCTTGTGCTGACCCAG 119 53

Table 2

Fibroblasts (NHDF) Control 1 µg 10 µg 100 µg
PPAR gamma 1.78 2.31 7.31 30.7
VDR 1.76 2.85 9.67 31.5

Conclusion

The findings from this study indicate that metadichol has the potential to regulate CD14 expression in human embryonic stem cells (hESCs) and fibroblasts, suggesting novel therapeutic strategies for the treatment of inflammatory diseases.

References

1. Tuckov L, Faré M, Iwase T, Takada Y, Tsukada-Hagihara H. Functional analysis of epithelial cells in vivo express and release soluble CD14: a reevaluation of LPS activation of epithelial cells. Infect Immun. 2001; 69(6):3772-3781.

2. Warwick T, Schulz M.H., Günther S, et al. An investigation of the hierarchical regulatory network of the vitamin D-induced transcriptional response uncovers novel regulators and demonstrates total VDR dependency in monocytes. Sci Rep. 2021; 11(1): 6518. doi:10.1038/s41598-021-86032-5.

3. Valdés-López JF, Veilla P, Urquijo-Inclán L, Barrera-Robles L. Function of CD14 expression and differentiation into monocytes or macrophages in promyelocytic cell lines: a novel strategy. Adv Pharm Bull. 2013; 3(2):329-332. doi:10.5681/apb.2013.05.

Interested in publishing your own research?
ESMED members can publish their research for free in our peer-reviewed journal.
Learn About Membership

Call for papers

Have a manuscript to publish in the society's journal?